Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

CDC backing for preventive Truvada could multiply Gilead's scripts 50-fold
Fierce Pharma
Thursday, May 15, 2014 - 11:11am
tags:
CDC, Truvada, HIV, Gilead Sciences
Reckitt Benckiser to develop XenoPort alcohol abuse drug
Yahoo/Reuters
Thursday, May 15, 2014 - 11:08am
tags:
alcoholism, Reckitt Benckiser, XenoPort, Suboxone
Merck KGaA Beats on Q1 Earnings
Yahoo/Zacks.com
Thursday, May 15, 2014 - 11:05am
tags:
earnings, Merck KGaA
Northwest Biotherapeutics Reports On Sarcoma Patient Treated With DCVAx-Direct
Seeking Alpha
Thursday, May 15, 2014 - 11:04am
tags:
Northwest Biotherapeutics, sarcoma, DCVax Direct
Why This Little-Known Biotech Is An Enticing Takeover And New-Products Play
Forbes
Thursday, May 15, 2014 - 11:02am
tags:
Spectrum Pharmaceuticals
Kindred Healthcare Offers to Acquire Gentiva Health
Bloomberg
Thursday, May 15, 2014 - 11:01am
tags:
Kindred Healthcare, home healthcare, Gentiva Health Services, M&A
Roche Immune Therapy Drug Helps Bladder Cancer Patients
Bloomberg
Thursday, May 15, 2014 - 11:00am
tags:
Roche, bladder cancer, MPDL3280A
Promising cancer drug data helps AstraZeneca in Pfizer fight
Yahoo/Reuters
Thursday, May 15, 2014 - 10:57am
tags:
Pfizer, AstraZeneca, AZD9291
Why Pfizer's Huge Offer for AstraZeneca Actually Makes Sense
Motley Fool
Thursday, May 15, 2014 - 9:48am
tags:
Pfizer, M&A, AstraZeneca
Boston Scientific to spend $415M on Bayer division
Yahoo/AP
Thursday, May 15, 2014 - 9:42am
tags:
Boston Scientific, Bayer, devices, M&A
ASCO '14 Preview: Blood Cancer Data from Pharmacyclics, Gilead, Abbvie
TheStreet.com
Thursday, May 15, 2014 - 8:29am
tags:
ASCO, Gilead Sciences, AbbVie, Pharmacyclics, Imbruvica, CLL, Idelalisib, mantle cell lymphoma, ABT-199
Eli Lilly's necitumumab improves OS in Phase III study
The Fly on the Wall
Thursday, May 15, 2014 - 8:26am
tags:
Eli Lilly, necitumumab, non-small cell lung cancer
Bristol, Merck, Roche immune therapies are cancer meeting focus
Yahoo/Reuters
Thursday, May 15, 2014 - 8:24am
tags:
Bristol-Myers Squibb, Merck, Roche, ASCO, cancer, anti-PD-1 immunotherapy
Lilly Loses Patent Dispute With Actavis Over Cancer Treatment
Bloomberg
Thursday, May 15, 2014 - 7:56am
tags:
patents, Actavis, Alimta, generics
Pfizer/AstraZeneca controversy rages on both sides of Atlantic
CNBC
Thursday, May 15, 2014 - 7:36am
tags:
Pfizer, AstraZeneca, M&A
Teva Loses Suit Against FDA Over Generic of Copaxone
Bloomberg
Thursday, May 15, 2014 - 7:35am
tags:
Teva, FDA, generics, Copaxone, Mylan Labs, Novartis, Sandoz, multiple sclerosis
Wockhardt recalls over 109,000 bottles of hypertension drug in U.S.
Yahoo/Reuters
Thursday, May 15, 2014 - 7:33am
tags:
recalls, Wockhardt, India
AstraZeneca leaves door ajar to Pfizer, despite hurdles
Yahoo/Reuters
Wednesday, May 14, 2014 - 6:40pm
tags:
Pfizer, M&A, AstraZeneca
AstraZeneca Cancer Drug Coveted by Pfizer Works in Trial
Bloomberg
Wednesday, May 14, 2014 - 6:39pm
tags:
Pfizer, AstraZeneca, AZD9291
SEC Casting Wide Net in Galena Investigation
TheStreet.com
Wednesday, May 14, 2014 - 4:36pm
tags:
SEC, Galena Biopharma, Lion Biotechnologies

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.